Biopsy Device Market Size, Sales, Analysis & Forecast to 2034

Biopsy Device Market Outlook from 2024 to 2034

After a thorough study of the healthcare domain, Future Market Insights speculates a positive yet moderate growth forecast for the biopsy device market from 2024 to 2034. Current projections indicate a valuation of US$ 2,274.1 million in 2024 for this market.

Thematic analysis of the biopsy device ecosystem points at a potential CAGR of 3.7% through 2034. Demand for biopsy devices is poised to attain a market value of US$ 3,270.4 million by the end of the present decade. The market for biopsy device is en route to growing 1.4x from 2024 to 2034.

Attributes	Key Insights
Estimated Market Size in 2024	US$ 2,274.1 million
Projected Market Value in 2034	US$ 3,270.4 million
Value-based CAGR from 2024 to 2034	3.70%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Market Trends and Highlights

Biopsy devices are used in different market verticals of the medical sector. Due to the widened applications, new openings for the subject market can be exploited, benefitting its growth.
For carrying out speedy biopsy processes, point-of-care diagnostic solutions are provided by medical organizations. The portability of these biopsy devices surges the propagation of the market, which is another key market trend.
Modernization of traditional biopsy techniques is another key trend. New techniques like liquid biopsy are emerging, replacing the conventional methods. Hence, this is another market-driving trend seen in the subject market.
Consumers have started giving more preference to personalized biopsy machines. Due to this, manufacturers are keen to meet these demands. Hence, this is another crucial market trend.

Growth Footprint of Biopsy Device Market from 2019 to 2023 vs. Expansion Road from 2024 to 2034

The biopsy device landscape has left a substantial growth legacy from 2019 to 2023. With substantial investments pouring in to develop innovative product lines, a CAGR of 6.4% was observed in the past five years alone. Based on the conditions prevailing in the market, the biopsy device market yielded revenues worth US$ 2,123.4 million in 2023.

The increased number of cancer patients is the foremost market driver during the historical period. The rising prevalence of cancer brought attention to the need for early detection of the disease. Consequently, the demand for biopsy devices surged, driving the subject market.

Various government initiatives to bolster the healthcare sector helped the global biopsy device market propel. Due to measures taken to uplift the industry, many benefits like enhanced monetary support, relieved legal policies, etc., helped the subject market. Hence, this was another important market driver.

Historical CAGR from 2019 to 2023	6.40%
Forecast CAGR from 2024 to 2034	3.70%

The forecasted period focuses more on technological advancements. Innovation will be fostered due to technology disruption, helping the subject market propel. In addition, new biopsy devices can be introduced in the market, leveraging innovation.

The increasing prevalence of lifestyle-related diseases and chronic diseases will lead to rising demand for frequent check-ups. Hence, this is another important market driver for the subject industry.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Market Drivers

The rising prevalence of chronic diseases drives the demand for early check-up devices. This surges the demand for the manufacturing of biopsy devices, propelling the market.
Governments have been investing heavily to develop the medical sector. Due to this, the industry's scope of innovation and product development is enhanced, surging cutting-edge products.
Increasing inclination towards minimally invasive treatments surges biopsy devices. Consequently, this drives the subject market.
Rising awareness about preventive check-ups surges the demand for biopsy devices as they provide a detailed check-up to the patient, giving prior ideas regarding the diseases. Hence, this is another crucial market driver.

Market Challenges

Integrating changing biopsy methods into traditional methods or devices might be a key challenge for the global biopsy device market.
Appropriate ethical and legal procedures must be followed. If these processes are not followed, it might threaten the market greatly.
Due to the fierce competition, the scope of innovation and expansion is reduced, hampering the market growth.

Comparative View of Adjacent Markets

The breast biopsy devices market and the lung biopsy systems market are the two adjacent markets to the biopsy device market. These markets are analyzed by Future Market Insights to provide a complete overview of the market

Biopsy Device Market:

Attributes	Biopsy Device Market
CAGR from 2024 to 2034	3.70%
Key Trends	Governments have been investing significantly in developing R&D facilities for biopsy devices. It is a key market trend.
Growth Factor	Growth in the healthcare sector and increased prevalence of lifestyle-related diseases and life-threatening diseases surge the market.

Breast Biopsy Devices Market:

Attributes	Breast Biopsy Devices Market
CAGR from 2024 to 2034	5.5%
Key Trends	Rising acceptance of liquid biopsies is a key trend pushing the market forward.
Growth Factor	The increased prevalence of breast cancer cases worldwide has been the foremost market driver.

Lung Biopsy Systems Market:

Attributes	Lung Biopsy Systems Market
CAGR from 2024 to 2034	9.4%
Key Trends	Increased activity of the health insurance companies assists the subject market. It is a key market trend.
Growth Factor	Growing awareness regarding chronic diseases like cancer fuels the market growth.

Country-wise Analysis

Forecast CAGRs from 2024 to 2034

Countries	Forecasted CAGR
Canada	2.60%
France	4.30%
Spain	4.10%
India	5.80%
Thailand	4.50%

The Developed Medical Infrastructure Helps the Canadian Market Grow

The projected market advancement for the biopsy device market in Canada is at a sluggish CAGR of 2.60%.
The Canadian government has focused on developing medical facilities and infrastructure. This creates a niche for medical professionals in many market verticals.
Due to medical advancements and the developed healthcare sector, the scope of growth of the subject market is greater in the country.
Apart from this, the private healthcare sector is emerging, increasing the accessibility of biopsy devices to patients.
Therefore, these drivers fuel the market growth.

Key Growth Prospects for Biopsy Device Market Expansion in France

France forecasts a near-to-moderate advancement rate and promises to fuel the subject market at a CAGR of 4.30% through 2034.
This market advancement is attributed to the government’s investments in the healthcare industry.
Various policies have been implemented, fostering higher expenditure on medical facilities, which surges the demand for medical devices.
Due to this, biopsy devices have come in demand, which fuels the subject market.
Further, advancements in the medical field assist the propelling market, helping the subject market grow.

Adopting Liquid Biopsy in Spain Fuels the Biopsy Device Market

Different trends in the global biopsy device market can be witnessed. Liquid biopsy is one of these trends.
Spanish medical professionals and institutes have started to adopt this technique to test patients’ responses and treat them accordingly.
Apart from this, it allows them to analyse the disease progression better than traditional biopsy methods.
Consequently, this drives the subject market in the country. Apart from this, the support from the Spanish government also fuels this transition.
Hence, these market drivers push the subject market at a CAGR of 4.10%.

Increased Prevalence of Lifestyle-Related Diseases Drives the Indian Market

India registers the highest advancement rate for the biopsy device market due to various key factors. It forecasts the market to propel a moderate CAGR of 5.80% through 2034.
The fundamental driving force for the market is the rising prevalence of lifestyle-related diseases, including diabetes and hypertension.
Further, cases of life-threatening diseases like cancer are also increasing, surging for early detection of diseases.
Hence, this generates demand for biopsy devices, driving the market.

Medical Tourism Supports the Growth of the Thai Biopsy Device Market

Thailand registers the market progression at a CAGR of 4.50% through 2034.
This market advancement is attributed to increased tourism in Thailand, supporting local medical professionals and institutions.
Apart from this, medical tourism supports the biopsy device market by surging the demand for medical instruments for early disease detection.
Consequently, it supports the subject market as biopsy devices gain rising importance amidst the abovementioned factors.
Therefore, this is a crucial market driver for the Thai market.

Category-wise Insights

Category	Product Type - Needles
Market Share in 2024	36.6%
Market Segment Drivers	Due to the high reliability of needle biopsy, medical professionals prefer this market segment, and hence, it surges the demand for the subject segment. Biopsy treatment given under this segment is less invasive. Due to this, it provides comfort to patients. Hence, this surges the demand for the segment. The better recovery time adds points to the segment’s account, fueling its growth.

Category	Application - Medical Diagnosis
Market Share in 2024	61.3%
Market Segment Drivers	Increased prevalence of medical awareness surges patients to preventive check-ups. This fuels the progress of the market segment. The accuracy of medical diagnosis is more, which propels the trustworthiness of the segment. Hence, consumers prefer the segment more. Preserving and researching infected tissues with a rare disease can develop medical science. This advances the market segment.

Competitive Landscape

The competitive landscape is robust, leaving little room for emerging marketers to secure significant market share. Consequently, new entrants must focus on automation, technological integration, and product innovation for a decisive market position. Brand positioning must be exclusive for a competitive edge.

Existing market players have been influencing the market drastically with many key expansion strategies. These strategies include product innovation, strategic collaborations, market diversification, global market penetration, and other exclusive business formulations. Due to these key moves, the competitive space of the global biopsy device market could be clearer.

Key Market Developments

In March 2022, B. Braun Melsungen AG sold its hospital services business, its provider in Colombia. This strategic decision was taken to neutralize deteriorating business conditions in the country. Moreover, it has given stability to the organization.
In May 2023, Becton, Dickinson, and Company introduced the world with the first spectral cell sorter with high-speed cell imaging. This innovation in the product will help scientists and researchers gain knowledge about cells. This bolsters the market position of the said organization.
In February 2024, Hologic, Inc. introduced an FDA-cleared digital cytology system. This gives the organization a competitive niche as the product launched is the first-ever system in the world. This will help diagnose cervical cancer better.

Key Coverage of Biopsy Device Market Report

Encompassing the market landscape in terms of its dynamics and forces affecting it.
Key coverage of the competitive landscape and expansion strategies of market players.
Market forecasts and predictions with the help of theoretical frameworks for assistance.
Key market developments made by allied markets.
Emerging regions’ analysis and lucrative opportunities in developed countries

Report Scope

Attributes	Details
Estimated Market Size in 2024	US$ 2274.1 million
Projected Market Valuation in 2034	US$ 3270.4 million
Value-based CAGR 2024 to 2034	3.70%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in US$ million
Key Regions Covered	North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East and Africa
Key Market Segments Covered	By Product Type By Application By End Use Region
Key Countries Profiled	The United States Canada Brazil Mexico Germany The United Kingdom France Spain Italy Poland Russia Czech Republic Romania India Bangladesh Australia New Zealand China Japan South Korea GCC Countries South Africa Israel
Key Companies Profiled	CR Bard Becton, Dickinson, and Company B. Braun Melsungen AG Hologic Inc. Cook Medical Devicor Medical Products Inc. Argon Medical Inc.

Biopsy Device Market - Key Segments

By Product Type:

Guidance System
Needles
Guns
Reagents and Kits
Others

By Application:

Medical Diagnosis
Scientific Research

By End Use:

Hospital
Specialized Oncology Centres
Diagnostic Centers
Research Institutes

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East and Africa

Frequently Asked Questions

At what rate is the biopsy device market propelling?

The biopsy device market is estimated to propel at a CAGR of 3.7% through 2034.

What will the market size of the biopsy device market be by 2034?

The biopsy device market will achieve a market valuation of US$ 3270.4 million in 2034.

What will the market size of the biopsy device market be by 2024?

The biopsy device market will achieve a market valuation of US$ 2274.1 million in 2024.

Based on application, which category holds the highest market space in the biopsy device market?

The biopsy device market's medical diagnosis segment holds 61.3% of the market space, the largest among all other categories.

Based on product type, which category holds the highest market space in the biopsy device market?

The biopsy device market's needles segment holds 36.6% of the market space, the largest among all other categories.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Product Life Cycle Analysis

3.5. Supply Chain Analysis

3.5.1. Supply Side Participants and their Roles

3.5.1.1. Manufacturer

3.5.2. Value Added and Value Created at Node in the Supply Chain

3.5.3. List of Raw Material Suppliers

3.5.4. List of Existing and Potential Buyer’s

3.6. Investment Feasibility Matrix

3.7. Value Chain Analysis

3.7.1. Profit Margin Analysis

3.8. PESTLE and Porter’s Analysis

3.9. Regulatory Landscape

3.9.1. By Key Regions

3.9.2. By Key Countries

3.10. Regional Parent Market Outlook

3.11. Production and Consumption Statistics

3.12. Import and Export Statistics

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023

4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2019 to 2023

5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2024 to 2034

5.3.1. Guidance System

5.3.2. Needles

5.3.3. Guns

5.3.4. Others

5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019 to 2023

5.5. Absolute $ Opportunity Analysis By Product Type, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2019 to 2023

6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2024 to 2034

6.3.1. Medical Diagnosis

6.3.2. Scientific Research

6.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023

6.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End Use

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End Use, 2019 to 2023

7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End Use, 2024 to 2034

7.3.1. Hospital

7.3.2. Specialized Oncology Centres

7.3.3. Diagnostic Centres

7.3.4. Research Institutes

7.4. Y-o-Y Growth Trend Analysis By End Use, 2019 to 2023

7.5. Absolute $ Opportunity Analysis By End Use, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

8.1. Introduction

8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023

8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034

8.3.1. North America

8.3.2. Latin America

8.3.3. Western Europe

8.3.4. Eastern Europe

8.3.5. South Asia and Pacific

8.3.6. East Asia

8.3.7. Middle East and Africa

8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

9.2.1. By Country

9.2.1.1. USA

9.2.1.2. Canada

9.2.2. By Product Type

9.2.3. By Application

9.2.4. By End Use

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Product Type

9.3.3. By Application

9.3.4. By End Use

9.4. Key Takeaways

10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

10.2.1. By Country

10.2.1.1. Brazil

10.2.1.2. Mexico

10.2.1.3. Rest of Latin America

10.2.2. By Product Type

10.2.3. By Application

10.2.4. By End Use

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Product Type

10.3.3. By Application

10.3.4. By End Use

10.4. Key Takeaways

11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

11.2.1. By Country

11.2.1.1. Germany

11.2.1.2. UK

11.2.1.3. France

11.2.1.4. Spain

11.2.1.5. Italy

11.2.1.6. Rest of Western Europe

11.2.2. By Product Type

11.2.3. By Application

11.2.4. By End Use

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Product Type

11.3.3. By Application

11.3.4. By End Use

11.4. Key Takeaways

12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

12.2.1. By Country

12.2.1.1. Poland

12.2.1.2. Russia

12.2.1.3. Czech Republic

12.2.1.4. Romania

12.2.1.5. Rest of Eastern Europe

12.2.2. By Product Type

12.2.3. By Application

12.2.4. By End Use

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Product Type

12.3.3. By Application

12.3.4. By End Use

12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

13.2.1. By Country

13.2.1.1. India

13.2.1.2. Bangladesh

13.2.1.3. Australia

13.2.1.4. New Zealand

13.2.1.5. Rest of South Asia and Pacific

13.2.2. By Product Type

13.2.3. By Application

13.2.4. By End Use

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Product Type

13.3.3. By Application

13.3.4. By End Use

13.4. Key Takeaways

14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

14.2.1. By Country

14.2.1.1. China

14.2.1.2. Japan

14.2.1.3. South Korea

14.2.2. By Product Type

14.2.3. By Application

14.2.4. By End Use

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Product Type

14.3.3. By Application

14.3.4. By End Use

14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

15.2.1. By Country

15.2.1.1. GCC Countries

15.2.1.2. South Africa

15.2.1.3. Israel

15.2.1.4. Rest of MEA

15.2.2. By Product Type

15.2.3. By Application

15.2.4. By End Use

15.3. Market Attractiveness Analysis

15.3.1. By Country

15.3.2. By Product Type

15.3.3. By Application

15.3.4. By End Use

15.4. Key Takeaways

16. Key Countries Market Analysis

16.1. USA

16.1.1. Pricing Analysis

16.1.2. Market Share Analysis, 2023

16.1.2.1. By Product Type

16.1.2.2. By Application

16.1.2.3. By End Use

16.2. Canada

16.2.1. Pricing Analysis

16.2.2. Market Share Analysis, 2023

16.2.2.1. By Product Type

16.2.2.2. By Application

16.2.2.3. By End Use

16.3. Brazil

16.3.1. Pricing Analysis

16.3.2. Market Share Analysis, 2023

16.3.2.1. By Product Type

16.3.2.2. By Application

16.3.2.3. By End Use

16.4. Mexico

16.4.1. Pricing Analysis

16.4.2. Market Share Analysis, 2023

16.4.2.1. By Product Type

16.4.2.2. By Application

16.4.2.3. By End Use

16.5. Germany

16.5.1. Pricing Analysis

16.5.2. Market Share Analysis, 2023

16.5.2.1. By Product Type

16.5.2.2. By Application

16.5.2.3. By End Use

16.6. UK

16.6.1. Pricing Analysis

16.6.2. Market Share Analysis, 2023

16.6.2.1. By Product Type

16.6.2.2. By Application

16.6.2.3. By End Use

16.7. France

16.7.1. Pricing Analysis

16.7.2. Market Share Analysis, 2023

16.7.2.1. By Product Type

16.7.2.2. By Application

16.7.2.3. By End Use

16.8. Spain

16.8.1. Pricing Analysis

16.8.2. Market Share Analysis, 2023

16.8.2.1. By Product Type

16.8.2.2. By Application

16.8.2.3. By End Use

16.9. Italy

16.9.1. Pricing Analysis

16.9.2. Market Share Analysis, 2023

16.9.2.1. By Product Type

16.9.2.2. By Application

16.9.2.3. By End Use

16.10. Poland

16.10.1. Pricing Analysis

16.10.2. Market Share Analysis, 2023

16.10.2.1. By Product Type

16.10.2.2. By Application

16.10.2.3. By End Use

16.11. Russia

16.11.1. Pricing Analysis

16.11.2. Market Share Analysis, 2023

16.11.2.1. By Product Type

16.11.2.2. By Application

16.11.2.3. By End Use

16.12. Czech Republic

16.12.1. Pricing Analysis

16.12.2. Market Share Analysis, 2023

16.12.2.1. By Product Type

16.12.2.2. By Application

16.12.2.3. By End Use

16.13. Romania

16.13.1. Pricing Analysis

16.13.2. Market Share Analysis, 2023

16.13.2.1. By Product Type

16.13.2.2. By Application

16.13.2.3. By End Use

16.14. India

16.14.1. Pricing Analysis

16.14.2. Market Share Analysis, 2023

16.14.2.1. By Product Type

16.14.2.2. By Application

16.14.2.3. By End Use

16.15. Bangladesh

16.15.1. Pricing Analysis

16.15.2. Market Share Analysis, 2023

16.15.2.1. By Product Type

16.15.2.2. By Application

16.15.2.3. By End Use

16.16. Australia

16.16.1. Pricing Analysis

16.16.2. Market Share Analysis, 2023

16.16.2.1. By Product Type

16.16.2.2. By Application

16.16.2.3. By End Use

16.17. New Zealand

16.17.1. Pricing Analysis

16.17.2. Market Share Analysis, 2023

16.17.2.1. By Product Type

16.17.2.2. By Application

16.17.2.3. By End Use

16.18. China

16.18.1. Pricing Analysis

16.18.2. Market Share Analysis, 2023

16.18.2.1. By Product Type

16.18.2.2. By Application

16.18.2.3. By End Use

16.19. Japan

16.19.1. Pricing Analysis

16.19.2. Market Share Analysis, 2023

16.19.2.1. By Product Type

16.19.2.2. By Application

16.19.2.3. By End Use

16.20. South Korea

16.20.1. Pricing Analysis

16.20.2. Market Share Analysis, 2023

16.20.2.1. By Product Type

16.20.2.2. By Application

16.20.2.3. By End Use

16.21. GCC Countries

16.21.1. Pricing Analysis

16.21.2. Market Share Analysis, 2023

16.21.2.1. By Product Type

16.21.2.2. By Application

16.21.2.3. By End Use

16.22. South Africa

16.22.1. Pricing Analysis

16.22.2. Market Share Analysis, 2023

16.22.2.1. By Product Type

16.22.2.2. By Application

16.22.2.3. By End Use

16.23. Israel

16.23.1. Pricing Analysis

16.23.2. Market Share Analysis, 2023

16.23.2.1. By Product Type

16.23.2.2. By Application

16.23.2.3. By End Use

17. Market Structure Analysis

17.1. Competition Dashboard

17.2. Competition Benchmarking

17.3. Market Share Analysis of Top Players

17.3.1. By Regional

17.3.2. By Product Type

17.3.3. By Application

17.3.4. By End Use

18. Competition Analysis

18.1. Competition Deep Dive

18.1.1. Becton, Dickinson and Company

18.1.1.1. Overview

18.1.1.2. Product Portfolio

18.1.1.3. Profitability by Market Segments

18.1.1.4. Sales Footprint

18.1.1.5. Strategy Overview

18.1.1.5.1. Marketing Strategy

18.1.1.5.2. Product Strategy

18.1.1.5.3. Channel Strategy

18.1.2. Hologic Inc.

18.1.2.1. Overview

18.1.2.2. Product Portfolio

18.1.2.3. Profitability by Market Segments

18.1.2.4. Sales Footprint

18.1.2.5. Strategy Overview

18.1.2.5.1. Marketing Strategy

18.1.2.5.2. Product Strategy

18.1.2.5.3. Channel Strategy

18.1.3. Danaher Corporation

18.1.3.1. Overview

18.1.3.2. Product Portfolio

18.1.3.3. Profitability by Market Segments

18.1.3.4. Sales Footprint

18.1.3.5. Strategy Overview

18.1.3.5.1. Marketing Strategy

18.1.3.5.2. Product Strategy

18.1.3.5.3. Channel Strategy

18.1.4. Cook Medical

18.1.4.1. Overview

18.1.4.2. Product Portfolio

18.1.4.3. Profitability by Market Segments

18.1.4.4. Sales Footprint

18.1.4.5. Strategy Overview

18.1.4.5.1. Marketing Strategy

18.1.4.5.2. Product Strategy

18.1.4.5.3. Channel Strategy

18.1.5. Boston Scientific Corporation

18.1.5.1. Overview

18.1.5.2. Product Portfolio

18.1.5.3. Profitability by Market Segments

18.1.5.4. Sales Footprint

18.1.5.5. Strategy Overview

18.1.5.5.1. Marketing Strategy

18.1.5.5.2. Product Strategy

18.1.5.5.3. Channel Strategy

18.1.6. Intact Medical Corporation

18.1.6.1. Overview

18.1.6.2. Product Portfolio

18.1.6.3. Profitability by Market Segments

18.1.6.4. Sales Footprint

18.1.6.5. Strategy Overview

18.1.6.5.1. Marketing Strategy

18.1.6.5.2. Product Strategy

18.1.6.5.3. Channel Strategy

18.1.7. Gallini Medical

18.1.7.1. Overview

18.1.7.2. Product Portfolio

18.1.7.3. Profitability by Market Segments

18.1.7.4. Sales Footprint

18.1.7.5. Strategy Overview

18.1.7.5.1. Marketing Strategy

18.1.7.5.2. Product Strategy

18.1.7.5.3. Channel Strategy

18.1.8. TSK Laboratory Europe BV

18.1.8.1. Overview

18.1.8.2. Product Portfolio

18.1.8.3. Profitability by Market Segments

18.1.8.4. Sales Footprint

18.1.8.5. Strategy Overview

18.1.8.5.1. Marketing Strategy

18.1.8.5.2. Product Strategy

18.1.8.5.3. Channel Strategy

18.1.9. Argon Medical Devices

18.1.9.1. Overview

18.1.9.2. Product Portfolio

18.1.9.3. Profitability by Market Segments

18.1.9.4. Sales Footprint

18.1.9.5. Strategy Overview

18.1.9.5.1. Marketing Strategy

18.1.9.5.2. Product Strategy

18.1.9.5.3. Channel Strategy

18.1.10. B. Braun Melsungen AG

18.1.10.1. Overview

18.1.10.2. Product Portfolio

18.1.10.3. Profitability by Market Segments

18.1.10.4. Sales Footprint

18.1.10.5. Strategy Overview

18.1.10.5.1. Marketing Strategy

18.1.10.5.2. Product Strategy

18.1.10.5.3. Channel Strategy

18.1.11. Cardinal Health Inc.

18.1.11.1. Overview

18.1.11.2. Product Portfolio

18.1.11.3. Profitability by Market Segments

18.1.11.4. Sales Footprint

18.1.11.5. Strategy Overview

18.1.11.5.1. Marketing Strategy

18.1.11.5.2. Product Strategy

18.1.11.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Biopsy Device Market

Biopsy Device Market Analysis by Needles, Guidance Systems and Other Product Types from 2024 to 2034